Industry › BioTech

Press Releases

华领医药与国药控股签署供应链战略合作协议加速商业化布局

Sep 15, 2021 14:37 HKT/SGT

華領醫藥與國藥控股簽署供應鏈戰略合作協議加速商業化佈局

Sep 15, 2021 14:36 HKT/SGT

Hua and Sinopharm Announced Supply Chain Strategic Cooperation

Sep 15, 2021 14:35 HKT/SGT

エーザイ、国際的な環境イニシアチブ「RE100」に加盟

Sep 15, 2021 11:00 JST

Eisai to Join The Global Environmental Initiative "RE100"

Sep 14, 2021 16:46 HKT/SGT

Eisai to Present Abstracts on Oncology Products and Pipeline at ESMO Virtual Congress 2021

Sep 14, 2021 11:36 HKT/SGT

エーザイ、欧州臨床腫瘍学会年次総会におけるエーザイのがん領域の開発品・製品等に関する演題について

Sep 14, 2021 09:00 JST

Legend Capital Led a New Round of Investment of Etana

Sep 14, 2021 08:42 HKT/SGT

AbbVie, Eisai, and EA Pharma Launch "Humira Support Tool Ordering Service for Patients"

Sep 13, 2021 15:37 HKT/SGT

미 FDA, 휴머니젠의 코로나19 환자용 치료제 렌질루맙 긴급사용승인(EUA) 거부

Sep 13, 2021 11:00 HKT/SGT

君联资本上半年收获4个MedTech IPO：深耕长线，聚焦创新

Sep 10, 2021 18:38 HKT/SGT

君聯資本上半年收穫4個MedTech IPO：深耕長線，聚焦創新

Sep 10, 2021 18:37 HKT/SGT

Legend Capital enjoys 4 MedTech IPOs in 1H2021, focusing on long-term and innovation investment

Sep 10, 2021 18:36 HKT/SGT

中基长寿科学与Vivo Miracle订立销售代理合约

Sep 10, 2021 15:56 HKT/SGT

中基長壽科學與Vivo Miracle訂立銷售代理合約

Sep 10, 2021 15:55 HKT/SGT

阿诺医药宣布AN2025、AN0025与atezolizumab三联治疗晚期实体瘤1a期临床在美国完成首例患者给药

Sep 08, 2021 11:33 HKT/SGT

阿諾醫藥宣佈AN2025、AN0025與atezolizumab三聯治療晚期實體瘤1a期臨床在美國完成首例患者給藥

Sep 08, 2021 11:32 HKT/SGT

Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors

Sep 08, 2021 11:31 HKT/SGT

다나까귀금속공업：미국의 의료기기 벤처 펀드 ‘Ambix Life Science Fund’ 에 출자

Sep 08, 2021 10:00 HKT/SGT

田中貴金屬工業：對美國的醫療儀器風險基金「Ambix Life Science Fund」進行出資

Sep 08, 2021 10:00 HKT/SGT